Global Enalapril Sales Market Report 2021

Enalapril is used to treat hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction.[9] It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects.[10] It is widely used in chronic kidney failure.[11] Furthermore, enalapril is an emerging treatment for psychogenic polydipsia. 

Market Analysis and Insights: Global Enalapril Market
The global Enalapril market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Enalapril Scope and Market Size
The global Enalapril market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enalapril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
2.5mg
5mg
10mg
20mg

Segment by Application
Hospital
Drugs Store

The Enalapril market is analysed and market size information is provided by regions (countries). Segment by Application, the Enalapril market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Apotex Inc
Apothecon Inc Div Bristol Myers Squibb
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Krka Dd Novo Mesto
Lek Pharmaceuticals D D
Mylan Pharmaceuticals Inc
Ranbaxy Laboratories Ltd
Sandoz Inc
Taro Pharmaceutical Industries Ltd
Teva Pharmaceuticals Usa Inc
Watson Laboratories Inc
Wockhardt Americas Inc
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Hikma Farmaceutica (Portugal) Sa
Hospira Inc
Teva Parenteral Medicines Inc